- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Carmen Lawrence
News 27 results
Recognition
August 7, 2023
Benchmark Litigation Names Three King & Spalding Partners to its List of Top 250 Women in Litigation
Recognition
June 21, 2023
Crain’s New York Business Names Jennifer Daly and Carmen Lawrence to its 2023 Notable Women in Law List
Recognition
June 1, 2023
Chambers USA 2023 Recognizes 186 K&S Lawyers and 84 K&S Practice Groups as Leaders in Their Fields
In the News · Source: Law360
Events 5 results
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
November 10, 2020
13th Annual King & Spalding Medical Device Summit
Conference
May 1, 2019
6th Annual Cybersecurity & Privacy Summit
Insights 24 results
Client Alert
May 30, 2023
Bye-Bye Big Boys? The SEC Turns its Enforcement Focus to Private Deals
Client Alert
June 24, 2021
Repairing A “Crack” in Insider Trading Regulation: SEC Rule 10b5-1 Trading Plans Face Increased Scrutiny
Client Alert
April 8, 2021
SEC and FINRA Emphasize Cybersecurity, AML, and Reg BI as Key Areas of Focus for Broker-Dealer Examinations in 2021
Client Alert
April 1, 2021
SEC Division of Examinations – 2021 Priorities